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vival curves. The study population was compared to the general population (age
and gender-matched, 1-sample log-rank test).
Results: Mean age of the study population was 71±8.3 years, 24.1% female,
18% in CCS Class III/IV, and the mean EuroSCORE 2 was 3,5±2,6%. CR was
achieved in 532 patients (70.7%) and 31.8% had complete arterial revascular-
ization. Patients with CR were perfectly comparable with those with iCR, except
for age, since ICR patients were slightly older (72.5±7.5 vs 70.3±8.5, p<0.001).
Thirty-day mortality was 0.93% (7 patients) and late mortality 25.7% (193). Late
survival was significantly worse in ICR patients (1-, 5- and 12-year survival was
93.4±1.7%, 80.1±3.2%, and 36.2±6.7%, respectively, in ICR group vs 96.5±0.8%,
87.6±1.6%, and 53.0±3.8%, p=0.002). Age, peripheral vascular disease, left ven-
tricle function, CSS class and CR emerged as independent risk factors for late
mortality (p<0.01). It was interesting to find that CR was most beneficial in
patients younger than 60 years (p=0.006). On the contrary, octogenarian pa-
tients had similar survival irrespective the completeness of the revascularization
(p=0.63). Age, peripheral vascular disease, left ventricle function, CSS class and
CR emerged as independent risk factors for late mortality (p<0.01). Patients with
CR had a similar survival to that expected in an age and gender-matched general
population.
Conclusions: Concomitant AVR and CABG can be performed safely, with low
mortality. Surgery restores life expectancy to that of the general population. Com-
plete revascularization plays an important role on late survival, particularly in
younger patients. In contrast, octogenarian patients did not exhibited a survival
benefit after CR.
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Hyperglycemia enhances phospholipid production and expression of
coagulation proteins by valvular fibroblasts from patients with aortic
stenosis: a novel mechanisms linking diabetes to aortic stenosis
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Background: Type 2 diabetes is considered an important risk factor for aortic
stenosis (AS), however the role of hyperglycemia in the development and pro-
gression of AS and the underlying mechanism remain unclear.
Purpose: To evaluate if hyperglycemia leads to accelerated calcification and/or
expression of coagulatory proteins in human valvular interstitial cells (VICs) iso-
lated from aortic valves of patients with severe AS.
Methods: In order to initiate the process of calcification primary cultures of
VICs derived from 20 non-diabetic stenotic aortic valves were digested with col-
lagenase for 30 min at 37°C and grown in calcification medium containing β-
glycerofosforan, CaCl2 (1.5 mmol/l) and ascorbic acid (50 μg/mL) at 37°C and
5% CO2 up to 14 days. To induce hyperglycemia, VICs were supplemented with
glucose in the final concentration of 11 mM/L for the last 72 hours of culturing.
Non-glucose cultures were used as controls. For immunofluorescence analysis
of tissue factor (TF), FII and FX expression cells were seeded on coverslips in
6-well plates. For Raman microscopy, to study calcification process and changes
in lipid content, cells were seeded on CaF2 Raman grade polished windows. The
expression of FII, FX, and TF was analyzed by immunofluorescence, using cor-
responding monoclonal antibodies and visualized with the secondary antibod-
ies conjugated with fluorochrome. Evaluation of positive cells was performed as
a number of cells presenting antigen expression/total cell number. Raman data
were collected using a confocal Raman microscope WITec Alpha 300.
Results: VICs control cultures revealed the TF (10.8±1.9%) and FX
(73.7±20.5%), but not FII presence. Under hyperglycemic conditions VICs not
only enhanced the expression of TF (79.4±10.3%, an increase +68.6%, p<0.001)
and FX (85.85±4.77%, an increase +12.15%, p=0.03) but also revealed the ex-
pression of FII (78.41±11.39%, p<0.0001). In parallel, Raman images of VICs
maintained in osteogenic medium did not exhibit any signs of calcification after
14 days of growing but presented a substantial lipid concentration in the cyto-
plasm. However, after glucose supplementation Raman spectra of cells revealed
a significant increase in intensity of lipid bands, especially bands at 718 and 1094
cm-1 arising from phosphatidylcholine.
Conclusions: In human VICs transient hyperglycemia leads to excessive syn-
thesis of proinflammatory phospholipids and an activation of coagulation, which
might facilitate AS in subjects with poorly controlled diabetes. Moreover, it is
tempting to speculate that abundant phospholipids synthesis might be consid-
ered as one of the pathophysiological drivers of AS.
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Bcl-2 associated athanogene 3 enhances alpha-B crystallin protein
turnover via activation of autophagy in the heart
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University, Shiwa-Gun, Yahabacho, Japan
Background: It is known that Bcl-2 associated athanogene 3 (BAG3) is strongly
expressed in cardiac muscle, and is also detectable in various tissues such as
skeletal muscle, smooth muscle, and neuronal tissue. BAG3 can directly bind
to Bcl-2 as well as heat shock protein (HSP) as a co-chaperone. In recent re-
search, myofibrillar degeneration, disruption of Z-disk architecture, and apoptotic
cell death were observed in the early postnatal period in BAG3 knockout mice.
Thus, BAG3 may play a cytoprotective role in cardiac muscle. In this study, we
examined BAG3 protein levels in alpha-B crystallin (CryAB) Arg120Gly (R120G)
transgenic (TG) mice, a mouse model for myofibrillar myopathy (MFM). In these
animals, accumulation of insoluble aggregates containing CryAB in cardiomy-
ocytes, a decrease in contractile function, and atrioventricular block and atrial
flutter occurred at approximately eight months of age. A marked increase in BAG3
was observed in CryAB R120G TG mouse hearts. However, little is known about
the precise role of increased BAG3 in cardiac muscle.
Methods and results: In order to understand the underlying mechanisms of the
functional role of increased cardiac BAG3 in CryAB R120G TG mice, we gener-
ated TG mice overexpressing BAG3 specifically in cardiac muscle, and analyzed
the phenotype of the mice. A decrease in fractional shortening and induction of
atrial natriuretic peptide (ANP) were seen in the BAG3 TG mice in which myocar-
dial BAG3 protein was increased 7–8 times of that in nontransgenic (NTG) mice.
Moreover, marked reductions in cardiac CryAB protein levels were detected in
BAG3 TG mice, while no differences in gene expression levels of cardiac CryAB
between NTG and BAG3 TG mice were seen. These results suggest that BAG3
may activate CryAB protein degradation in the heart. Therefore, we focused on
the ubiquitin-proteasome system and the autophagy system, which are known
as protein degradation mechanisms. We analyzed the cardiac CryAB protein lev-
els in BAG3 TG mice while the ubiquitin-proteasome system was inhibited by
treatment with bortezomib, or while the autophagy system was inhibited by treat-
ment with chloroquine. During treatment with bortezomib in NTG mice, CryAB
protein levels in the heart were enhanced. This result indicates that under normal
conditions, protein turnover of CryAB is performed by the ubiquitin-proteasome
system. In contrast, turnover of CryAB protein is regulated by both the ubiquitin-
proteasome system and the autophagy system in BAG3 TG mouse hearts.
Conclusion: BAG3 is critical for protein turnover of CryAB via activation of au-
tophagy in the heart, and the enhancement of BAG3 observed in CryAB R120G
TG mouse hearts may be due to an adaptive response to accumulation of aggre-
gates containing CryAB protein.
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Introduction: Invasive hemodynamic evaluation is a fundamental diagnostic
method in patients with pulmonary hypertension (PH). However, its prognostic
value in this group of patients is not fully established.
Purpose: To assess the prognostic impact of hemodynamic parameters of right
catheterization in patients with PH.
Methods: Prospective observational study of patients with PH undergoing right
and left catheterization for diagnostic confirmation and functional evaluation dur-
ing vasoreactivity test. Only patients with mean pulmonary arterial pressure (PAP)
>25 mmHg considered not secondary to left heart disease were included. A basal
evaluation of the conventional hemodynamic parameters, left and right ventricu-
lar function indexes, pulmonary and systemic vascular resistance indexes were
performed and they were re-evaluated during vasoreactivity test. The parame-
tres were analysed and related with overall mortality and with cardiac death or
hospitalization during clinical follow-up by Multivariate regression analysis of Cox.
Results: A total of 68 patients were included (71% females, mean age 53±17
years), 81% of whom were from group 1 (NICE) and 15% from group IV. The mean
value of mean pulmonary artery pressure was 47±16mmHg and mean right atrial
pressure was 11±7mmHg. During a median follow-up of 34 months, 7 patients
(10%) died and 25 (37%) were hospitalized for heart failure. Of all hemodynamic
parameters, the only independent predictor of mortality was the mean right atrial
pressure, for each 1mmHg rise, mortality risk increased by 12% (hazard ratio
(HR): 1, 12; 95% CI 1.02–1.23; p=0.018) and the risk of death or hospitaliza-
tion for cardiac causes was 17% (HR: 1.17, 95% CI: 1.00–1.37, P=0.050). The
prognosis was not influenced by the demonstration of pulmonary arterial vasore-
activity, magnitude of PAP elevation or pulmonary vascular resistance.
Conclusion: In patients with PH, invasive hemodynamic evaluation offers an ad-
dictional value in prognostic stratification. In particular, measurement of mean
right atrial pressure has been shown to be an independent predictor of mortality.
On the other hand, other parameters such as pulmonary arterial vasoreactivity,
although important in the definition of the therapeutic strategy, did not have an
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